PMID- 38523868 OWN - NLM STAT- MEDLINE DCOM- 20240326 LR - 20240326 IS - 1664-2392 (Print) IS - 1664-2392 (Electronic) IS - 1664-2392 (Linking) VI - 14 DP - 2023 TI - Quantitative assessment of OCT and OCTA parameters in diabetic retinopathy with and without macular edema: single-center cross-sectional analysis. PG - 1275200 LID - 10.3389/fendo.2023.1275200 [doi] LID - 1275200 AB - AIM: The retinal and choroidal parameters were analyzed to understand the impairment of microcirculation of both retina and choroid in patients with diabetic retinopathy (DR). METHODS: Fifty-five treatment-naive non-proliferative diabetic retinopathy (NPDR) patients (75 eyes) with type 2 diabetes mellitus (T2DM), including 28 patients (36 eyes) with diabetic macular edema (DME) and 27 patients (39 eyes) without DME, and 25 healthy subjects (47 eyes) were enrolled in this study. The following parameters of DR patients with and without DME were evaluated: the foveal avascular zone area (FAZ-a), FAZ perimeter (FAZ-p), FAZ circularity index (FAZ-CI), total subfoveal choroidal area (TCA), luminal area (LA), stromal area (SA), choroidal vascularity index (CVI), choriocapillaris flow area percentage, superficial capillary plexus (SCP), and deep capillary plexus (DCP). RESULTS: SCP, DCP, and the percentage of choriocapillaris flow area were significantly different between DR patients with and without DME. The DR patients presented lower LA, CVI, and FAZ-CI compared to those of healthy controls (all p < 0.05). The percentage of choriocapillaris flow area in DR patients with and without DME was significantly lower than that in healthy controls (p < 0.05). SCP and DCP were significantly correlated with FAZ-a and FAZ-p but presented insignificant associations with FAZ-CI. CONCLUSIONS: Optical coherence tomography (OCT) and OCT angiography (OCTA) parameters, such as LA, CVI, FAZ-CI, and the percentage of choriocapillaris flow area, were reduced compared to those in controls, indicating that the microcirculations of the retina and choroid in the macular area were impaired in DR patients with DME and without DME. CI - Copyright (c) 2024 Cui, Feng, Wu, Wang, Cui, Wang, Chang, Shang, Zhao, Liu and Qin. FAU - Cui, Yanyan AU - Cui Y AD - Department of Ophthalmology, The Second Hospital of Shandong University, Jinan, China. FAU - Feng, Dongfan AU - Feng D AD - Liaocheng People's Hospital, Liaocheng, China. FAU - Wu, Changlong AU - Wu C AD - Jinan 2nd People's Hospital, Jinan, China. FAU - Wang, Ping AU - Wang P AD - Ophthalmological Center, Affiliated Hospital of Weifang Medical University, Weifang, China. FAU - Cui, Ruoxi AU - Cui R AD - Nanchang University Queen Mary School, Nanchang, China. FAU - Wang, Xiaokun AU - Wang X AD - Civil Aviation Medical Center of CAAC Northeast Regional Administration, Shenyang, China. FAU - Chang, Weiwei AU - Chang W AD - Department of Ophthalmology, Affiliated Hospital of Jining Medical University, Jining, China. FAU - Shang, Weiwei AU - Shang W AD - Liaocheng People's Hospital, Liaocheng, China. FAU - Zhao, Bojun AU - Zhao B AD - Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. FAU - Liu, Jing AU - Liu J AD - Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China. FAU - Qin, Xuejiao AU - Qin X AD - Department of Ophthalmology, The Second Hospital of Shandong University, Jinan, China. LA - eng PT - Journal Article DEP - 20240308 PL - Switzerland TA - Front Endocrinol (Lausanne) JT - Frontiers in endocrinology JID - 101555782 SB - IM MH - Humans MH - *Diabetic Retinopathy/complications MH - *Macular Edema/etiology/complications MH - Cross-Sectional Studies MH - *Diabetes Mellitus, Type 2/complications MH - Tomography, Optical Coherence/methods PMC - PMC10960358 OTO - NOTNLM OT - OCT OT - OCTA OT - choroidal vascularity index OT - diabetic macular edema OT - fovea avascular zone COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2024/03/25 06:43 MHDA- 2024/03/26 06:44 PMCR- 2023/01/01 CRDT- 2024/03/25 04:20 PHST- 2023/08/09 00:00 [received] PHST- 2023/12/08 00:00 [accepted] PHST- 2024/03/26 06:44 [medline] PHST- 2024/03/25 06:43 [pubmed] PHST- 2024/03/25 04:20 [entrez] PHST- 2023/01/01 00:00 [pmc-release] AID - 10.3389/fendo.2023.1275200 [doi] PST - epublish SO - Front Endocrinol (Lausanne). 2024 Mar 8;14:1275200. doi: 10.3389/fendo.2023.1275200. eCollection 2023.